Recently, it has become clear that many of the intracellular signals m
ediated by Ang II receptors are similar to the signaling pathways acti
vated by receptor tyrosine kinases. In the present paper, we are repor
ting a full characterization of Ang II receptors in rat fetal membrane
s. We assayed binding of the Ang II antagonist [I-125]Sar(1)Ile(8)Ang
II and the AT(2) specific competitor [I-125]CGP42112. Both ligands exh
ibited a rapid equilibrium and a high specificity for Ang II receptors
. Competition studies confirmed the presence of both receptor subtypes
, with a predominance of AT(2) receptors and the following order of po
tency: CGP42112>Ang II > Losartan > PD123177. Immunoblotting studies o
f tyrosine phosphoproteins showed that Ang II (10(-6) M) mediates a ra
pid reduction in tyrosine phosphorylation of several proteins with app
arent molecular masses in the range of 30-45 kDa. Increasing concentra
tions of Ang II (10(-9)-10(-6) M) showed a dose-response behavior, sug
gesting a clear physiological role of the observed effect. The respons
e, blocked by Losartan and PD123177, seems to be mediated by both rece
ptor subtypes. These results clearly indicate that both Ang II recepto
rs mediate tyrosine dephosphorylation in early stages of development a
nd support a role of these receptors in growth and development. (C) 19
98 Elsevier Science B.V.